ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

ClinicalTrials.gov ID: NCT00817219

Public ClinicalTrials.gov record NCT00817219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 6:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00817219
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
LEO Pharma
Industry
Enrollment
33 participants

Conditions and interventions

Interventions

  • Calcipotriene plus betamethasone dipropionate ointment Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2009
Primary completion
Nov 30, 2011
Completion
Nov 30, 2011
Last update posted
Mar 11, 2025

2009 – 2011

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Center for Dermatology Clinical Research Fremont California 94538
University of California at San Diego/Rady Children's Hospital San Diego California 92123
Ameriderm Research Maitland Florida 32751
Northwestern University's Feinberg School of Medicine Chicago Illinois 60611-2997
Arlington Research Center Arlington Texas 76011
University of Texas-Dermatology Houston Texas 77030
Virginia Clinical Research, Inc. Norfolk Virginia 23507
DBA Dermatology Associates Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00817219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2025 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00817219 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →